Concepedia

Vasu Vasudevan

VV

Statistics

Publications

8

Citations

281

H-Index

8

Active since

1994

Affiliations

Eli Lilly (United States)(Current)

Vasu Vasudevan is an author at Eli Lilly (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1994–2005

8

Publications

8

Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors

Jian Liang, Richard E. Moore, Eric D. Moher et al. · Investigational New Drugs · 2005 · 75 citations

, , +6

Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles

Thomas A. Engler, Kelly Furness, Sushant Malhotra et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations · Full text

, , +11

Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors

Guoxin Zhu, Scott E. Conner, Xun Zhou et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 42 citations · Full text

, , +14

Regional‐Dependent Intestinal Absorption and Meal Composition Effects on Systemic Availability of LY303366, a Lipopeptide Antifungal Agent, in Dogs

Cheng Li, David Fleisher, Lü Li et al. · Journal of Pharmaceutical Sciences · 2001 · 41 citations · Full text

, , +17

The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element

Michael R. Wiley, Leonard C. Weir, Steven L. Briggs et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 26 citations

, , +11

1–5 of 8